메뉴 건너뛰기




Volumn 5, Issue 1, 2015, Pages

Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors

Author keywords

Biodistribution; J591 antibody; Lesion detectability; Neovasculature; Solid tumor

Indexed keywords

INDIUM 111; MONOCLONAL ANTIBODY J591; PROSTATE SPECIFIC MEMBRANE ANTIGEN;

EID: 84929008269     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/s13550-015-0104-4     Document Type: Article
Times cited : (63)

References (25)
  • 1
    • 0028939781 scopus 로고
    • Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement
    • COI: 1:STN:280:DyaK2M3gslShsQ%3D%3D, PID: 7534919
    • Murphy GP, Holmes EH, Boynton AL, Kenny GM, Ostenson RC, Erickson SJ, et al. Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement. Prostate. 1995;26:164–8.
    • (1995) Prostate. , vol.26 , pp. 164-168
    • Murphy, G.P.1    Holmes, E.H.2    Boynton, A.L.3    Kenny, G.M.4    Ostenson, R.C.5    Erickson, S.J.6
  • 2
    • 0031834798 scopus 로고    scopus 로고
    • Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer
    • COI: 1:STN:280:DyaK1c3nt1Sqtg%3D%3D, PID: 9610563
    • Murphy GP, Kenny GM, Ragde H, Wolfert RL, Boynton AL, Holmes EH, et al. Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer. Urology. 1998;51:89–97.
    • (1998) Urology. , vol.51 , pp. 89-97
    • Murphy, G.P.1    Kenny, G.M.2    Ragde, H.3    Wolfert, R.L.4    Boynton, A.L.5    Holmes, E.H.6
  • 3
    • 0032845060 scopus 로고    scopus 로고
    • Isolation and characterization of monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
    • COI: 1:CAS:528:DyaK1cXnsFChtLk%3D
    • Murphy GP, Greene TG, Tino WT, Boynton AL, Holmes EH. Isolation and characterization of monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen. J Urology. 1998;160:2396–401.
    • (1998) J Urology. , vol.160 , pp. 2396-2401
    • Murphy, G.P.1    Greene, T.G.2    Tino, W.T.3    Boynton, A.L.4    Holmes, E.H.5
  • 4
    • 0032400798 scopus 로고    scopus 로고
    • Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen
    • COI: 1:STN:280:DyaK1M%2FlsValsg%3D%3D, PID: 9840525
    • Murphy GP, Elgamal AA, Su SL, Bostwick DG, Holmes EH. Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen. Cancer. 1998;83:2259–69.
    • (1998) Cancer. , vol.83 , pp. 2259-2269
    • Murphy, G.P.1    Elgamal, A.A.2    Su, S.L.3    Bostwick, D.G.4    Holmes, E.H.5
  • 5
    • 0032188742 scopus 로고    scopus 로고
    • Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases
    • COI: 1:STN:280:DyaK1cvjsVSnug%3D%3D, PID: 9763084
    • Sweat SD, Pacelli A, Murphy GP, Bostwick DG. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology. 1998;52:637–40.
    • (1998) Urology. , vol.52 , pp. 637-640
    • Sweat, S.D.1    Pacelli, A.2    Murphy, G.P.3    Bostwick, D.G.4
  • 6
    • 0031042591 scopus 로고    scopus 로고
    • Prostate-specific membrane antigen expression in normal and malignant human tissues
    • COI: 1:STN:280:DyaK1M%2FjsFamtA%3D%3D, PID: 9815541
    • Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3:81–5.
    • (1997) Clin Cancer Res. , vol.3 , pp. 81-85
    • Silver, D.A.1    Pellicer, I.2    Fair, W.R.3    Heston, W.D.4    Cordon-Cardo, C.5
  • 7
    • 70449532104 scopus 로고    scopus 로고
    • Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers
    • COI: 1:CAS:528:DC%2BD1MXhsVens77I, PID: 19716160
    • Haffner MC, Kronberger IE, Ross JS, Sheehan CE, Zitt M, Muhlmann G, et al. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol. 2009;40:1754–61.
    • (2009) Hum Pathol. , vol.40 , pp. 1754-1761
    • Haffner, M.C.1    Kronberger, I.E.2    Ross, J.S.3    Sheehan, C.E.4    Zitt, M.5    Muhlmann, G.6
  • 8
    • 84864549393 scopus 로고    scopus 로고
    • High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity
    • COI: 1:CAS:528:DC%2BC38XhtFCrsLrK, PID: 22460809
    • Haffner MC, Laimer J, Chaux A, Schafer G, Obrist P, Brunner A, et al. High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity. Mod Pathol. 2012;25:1079–85.
    • (2012) Mod Pathol. , vol.25 , pp. 1079-1085
    • Haffner, M.C.1    Laimer, J.2    Chaux, A.3    Schafer, G.4    Obrist, P.5    Brunner, A.6
  • 9
    • 0030866116 scopus 로고    scopus 로고
    • Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium
    • COI: 1:CAS:528:DyaK2sXlvFensbo%3D, PID: 9288760
    • Liu H, Moy P, Kim S, Xia Y, Rajasekaran A, Navarro V, et al. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res. 1997;57:3629–34.
    • (1997) Cancer Res. , vol.57 , pp. 3629-3634
    • Liu, H.1    Moy, P.2    Kim, S.3    Xia, Y.4    Rajasekaran, A.5    Navarro, V.6
  • 10
    • 0032737848 scopus 로고    scopus 로고
    • Prostate-specific membrane antigen: much more than a prostate cancer marker
    • COI: 1:CAS:528:DyaK1MXnsVehurw%3D, PID: 10851338
    • Chang SS, Gaudin PB, Reuter VE, O’Keefe DS, Bacich DJ, Heston WD. Prostate-specific membrane antigen: much more than a prostate cancer marker. Mol Urol. 1999;3:313–20.
    • (1999) Mol Urol. , vol.3 , pp. 313-320
    • Chang, S.S.1    Gaudin, P.B.2    Reuter, V.E.3    O’Keefe, D.S.4    Bacich, D.J.5    Heston, W.D.6
  • 11
    • 0032740888 scopus 로고    scopus 로고
    • Prostate-specific membrane antigen is produced in tumor-associated neovasculature
    • COI: 1:CAS:528:DyaK1MXntlGltLw%3D, PID: 10537328
    • Chang SS, O’Keefe DS, Bacich DJ, Reuter VE, Heston WD, Gaudin PB. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res. 1999;5:2674–81.
    • (1999) Clin Cancer Res. , vol.5 , pp. 2674-2681
    • Chang, S.S.1    O’Keefe, D.S.2    Bacich, D.J.3    Reuter, V.E.4    Heston, W.D.5    Gaudin, P.B.6
  • 12
    • 34548462642 scopus 로고    scopus 로고
    • Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms
    • PID: 17826525
    • Baccala A, Sercia L, Li J, Heston W, Zhou M. Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms. Urology. 2007;70:385–90.
    • (2007) Urology. , vol.70 , pp. 385-390
    • Baccala, A.1    Sercia, L.2    Li, J.3    Heston, W.4    Zhou, M.5
  • 14
    • 0038315416 scopus 로고    scopus 로고
    • Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor
    • COI: 1:CAS:528:DC%2BD3sXjtlKnsbw%3D
    • Smith-Jones PM, Vallabhajosula S, Navarro V, Bastidas D, Goldsmith SJ, Bander NH. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. J Nuc Med. 2003;44:610–7.
    • (2003) J Nuc Med. , vol.44 , pp. 610-617
    • Smith-Jones, P.M.1    Vallabhajosula, S.2    Navarro, V.3    Bastidas, D.4    Goldsmith, S.J.5    Bander, N.H.6
  • 15
    • 4243489788 scopus 로고    scopus 로고
    • Phase 1 clinical trial targeting a monoclonal antibody (mAb) to the extracellular domain of prostate specific membrane antigen (PSMAext) in patients with hormone-independent prostate cancer [abstract 1872]
    • Bander NH, Nanus D, Bremer S. Phase 1 clinical trial targeting a monoclonal antibody (mAb) to the extracellular domain of prostate specific membrane antigen (PSMAext) in patients with hormone-independent prostate cancer [abstract 1872]. Proc Am Soc Clin Oncol. 2000;19:477a.
    • (2000) Proc Am Soc Clin Oncol , vol.19 , pp. 477
    • Bander, N.H.1    Nanus, D.2    Bremer, S.3
  • 16
    • 0142030952 scopus 로고    scopus 로고
    • Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen
    • COI: 1:CAS:528:DC%2BD3sXpt1Gksb0%3D, PID: 14571414
    • Bander NH, Nanus DM, Milowsky MI, Kostakoglu L, Vallabahajosula S, Goldsmith SJ. Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen. Semin Oncol. 2003;30:667–76.
    • (2003) Semin Oncol. , vol.30 , pp. 667-676
    • Bander, N.H.1    Nanus, D.M.2    Milowsky, M.I.3    Kostakoglu, L.4    Vallabahajosula, S.5    Goldsmith, S.J.6
  • 17
    • 12444285340 scopus 로고    scopus 로고
    • Radiolabeled humanized monoclonal antibodies to PSMA: phase I dose escalation studies with In-111-DOTA-hu-J591
    • Vallabhajosula S, Kuji I, Kostakoglu L, Smith-Jones PM, Zoe H, Bander NH, et al. Radiolabeled humanized monoclonal antibodies to PSMA: phase I dose escalation studies with In-111-DOTA-hu-J591. J Nucl Med. 2001;42:122P–3.
    • (2001) J Nucl Med. , vol.42 , pp. 122-123
    • Vallabhajosula, S.1    Kuji, I.2    Kostakoglu, L.3    Smith-Jones, P.M.4    Zoe, H.5    Bander, N.H.6
  • 18
    • 34249101981 scopus 로고    scopus 로고
    • Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
    • COI: 1:CAS:528:DC%2BD2sXkslOhur0%3D, PID: 17473203
    • Morris MJ, Pandit-Taskar N, Divgi CR, Bender S, O’Donoghue JA, Nacca A, et al. Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors. Clin Cancer Res. 2007;13(9):2707–13.
    • (2007) Clin Cancer Res , vol.13 , Issue.9 , pp. 2707-2713
    • Morris, M.J.1    Pandit-Taskar, N.2    Divgi, C.R.3    Bender, S.4    O’Donoghue, J.A.5    Nacca, A.6
  • 20
    • 46749104779 scopus 로고    scopus 로고
    • Antibody mass escalation study in patients with castration-resistant prostate cancer using (111)In-J591: lesion detectability and dosimetric projections for (90)Y radioimmunotherapy
    • PID: 18552139
    • Pandit-Taskar N, O’Donoghue JA, Morris MJ, Wills EA, Schwartz LH, Gonen M, et al. Antibody mass escalation study in patients with castration-resistant prostate cancer using (111)In-J591: lesion detectability and dosimetric projections for (90)Y radioimmunotherapy. J Nucl Med. 2008;49(7):1066–74.
    • (2008) J Nucl Med , vol.49 , Issue.7 , pp. 1066-1074
    • Pandit-Taskar, N.1    O’Donoghue, J.A.2    Morris, M.J.3    Wills, E.A.4    Schwartz, L.H.5    Gonen, M.6
  • 21
    • 27144544111 scopus 로고    scopus 로고
    • Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific-membrane antigen antibody J591 for castrate metastatic prostate cancer
    • COI: 1:CAS:528:DC%2BD2MXhtFartbvK, PID: 16243819
    • Morris MJ, Divgi CR, Pandit-Taskar N, Batraki M, Warren N, Nacca A, et al. Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific-membrane antigen antibody J591 for castrate metastatic prostate cancer. Clin Cancer Res. 2005;11:7454–61.
    • (2005) Clin Cancer Res. , vol.11 , pp. 7454-7461
    • Morris, M.J.1    Divgi, C.R.2    Pandit-Taskar, N.3    Batraki, M.4    Warren, N.5    Nacca, A.6
  • 22
    • 33947529429 scopus 로고    scopus 로고
    • Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors
    • COI: 1:CAS:528:DC%2BD2sXivF2mtLo%3D, PID: 17290063
    • Milowsky MI, Nanus DM, Kostakoglu L, Sheehan CE, Vallabhajosula S, Goldsmith SJ, et al. Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors. J Clin Oncol. 2007;25(5):540–7.
    • (2007) J Clin Oncol , vol.25 , Issue.5 , pp. 540-547
    • Milowsky, M.I.1    Nanus, D.M.2    Kostakoglu, L.3    Sheehan, C.E.4    Vallabhajosula, S.5    Goldsmith, S.J.6
  • 23
    • 0031940813 scopus 로고    scopus 로고
    • Simulation, analysis, and modeling software for tracer and pharmacokinetic studies
    • COI: 1:CAS:528:DyaK1cXitlygurg%3D, PID: 9550550
    • Barrett PH, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, et al. Simulation, analysis, and modeling software for tracer and pharmacokinetic studies. Metabolism. 1998;47:484–92.
    • (1998) Metabolism. , vol.47 , pp. 484-492
    • Barrett, P.H.1    Bell, B.M.2    Cobelli, C.3    Golde, H.4    Schumitzky, A.5    Vicini, P.6
  • 24
    • 0035186450 scopus 로고    scopus 로고
    • Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient
    • COI: 1:STN:280:DC%2BD3Mnntlyjsw%3D%3D, PID: 11719674
    • Gonen M, Panageas KS, Larson SM. Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient. Radiology. 2001;221:763–7.
    • (2001) Radiology. , vol.221 , pp. 763-767
    • Gonen, M.1    Panageas, K.S.2    Larson, S.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.